Animal experimentation is presented to the public as an ongoing debate between research scientists on one hand, and the animal protection community on the other. An opportunity to break out of this mindset presented itself in the form of a European Citizens’ Initiative, Stop Vivisection, which challenged Directive 2010/63/EU of the European Parliament and of the Council on the protection of animals for scientific purposes. The manifesto of the initiative called upon the European Commission to replace the existing Directive with a new proposal that does away with animal experimentation, and instead makes compulsory the use of human data as a predictive modality for the study of human diseases and responses to drugs. Although the Initiative succeeded in gathering the required one million signatures, the European Commission ultimately rejected the proposal. However, some of the lessons learned from the Initiative may well be relevant to the revision of Directive 2010/63/EU, due to take place by 2017.
Anon. (2010). Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. Official Journal of the European UnionL276, 20.10.2010, 33–79.
HerrmannK. (2015). The Ethics of Animal experimentation: Working towards a change paradigm change.Philadelphia, PA, USA: The University of Pennsylvania. Available at: https://call-for-papers.sas.upenn.edu/node/64426 (Accessed 26.07.16).
9.
CochraneB., & ByattK. (2014). A paradigm shift is needed to move biomedical research forward. British Medical Journal349, g4267.
10.
VallenderE.J., & MillerG.M. (2013). Nonhuman primate models in the genomic era: A paradigm shift. ILAR Journal54, 154–165.
11.
GrimmH. (2015). Turning apples into oranges? The harm–benefit analysis and how to take ethical considerations into account. ATLA43, P22–P24.
12.
AshbyM., & MenacheA. (2012). The composition of animal ethics committees needs to change. British Medical Journal345, e7627.
13.
GilesJ. (2006). Animal experiments under fire for poor design. Nature, London444, 981.
14.
Council of Europe (1986). European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes. European Treaty Series No. 123, 11 pp. Strasbourg, France: Council of Europe.
15.
Anon. (1999). Council Decision of 23 March 1998 concerning the conclusion by the Community of the European Convention for the protection of vertebrate animals used for experimental and other scientific purposes (1999/575/EC). Official Journal of the European UnionL222, 24.08.1999, 29–37.
16.
Anon. (2003). Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use. Official Journal of the European UnionL159, 27.06.2003, 46–94.
17.
BernardC. (1957). An Introduction to the Study of Experimental Medicine, 272 pp. New York, NY, USA: Dover.
18.
GreekR. (2014). The ethical implications for humans in light of the poor predictive value of animal models. International Journal of Clinical Medicine (Special Issue on Medical Ethics)5, 966–1005.
19.
GreekR., & MenacheA. (2013). Systematic reviews of animal models: Methodology versus epistemology. International Journal of Medical Sciences10, 206–221.
20.
GreekR., & GreekJ. (2010). Is the use of sentient animals in basic research justifiable?Philosophy, Ethics & Humanities in Medicine, 5, 14.
21.
GreekR., PippusA., & HansenL.A. (2012). The Nuremberg Code subverts human health and safety by requiring animal modeling. BMC Medical Ethics13, 16.
22.
GreekR. (2014). A discussion of the role of complex evolved systems in the development of invasive cardiovascular interventions as illustrated by the Blalock-Taussig Shunt and intra-arterial stents. Biological Systems3, doi: 10.4172/2329-6577.1000124.
23.
GreekR., & HansenL.A. (2013). Questions regarding the predictive value of one evolved complex adaptive system for a second: Exemplified by the SOD1 mouse. Progress in Biophysics & Molecular Biology113, 231–153.
24.
GreekR., MenacheA., & RiceM.J. (2012). Animal models in an age of personalized medicine. Personalized Medicine9, 47–64.
25.
GreekR., & RiceM.J. (2012). Animal models and conserved processes. Theoretical Biology & Medical Modelling9, doi: 10.1186/1742-4682-9-40.
26.
GreekR., ShanksN., & RiceM.J. (2011). The history and implications of testing thalidomide on animals. Journal of Philosophy, Science & Law11, October 3.
27.
ShanksN., & GreekR. (2009). Animal Models in Light of Evolution, 444 pp. Boca Raton, FL, USA: Brown Walker.
28.
ShanksN., GreekR., & GreekJ. (2009). Are animal models predictive for humans?Philosophy, Ethics & Humanities in Medicine, 4, 2.
29.
TsaiounK., BottlaenderM., & MabondzoA. (2009). ADDME — avoiding drug development mistakes early: Central nervous system drug discovery perspective. BMC Neurology9, Suppl. 1, S1.
Martic-KehlM.I., SchibliR., & SchubigerP.A. (2012). Can animal data predict human outcome? Problems and pitfalls of translational animal research. European Journal of Nuclear Medicine & Molecular Imaging39, 1492–1496.
33.
LangleyG. (2009). The validity of animal experiments in medical research. Revue Semestrielle de Droit Animalier1, 161–168.
34.
KnightA. (2008). Systematic reviews of animal experiments demonstrate poor contributions toward human healthcare. Reviews on Recent Clinical Trials3, 89–96.
35.
BaileyJ., ThewM., & BallsM. (2015). Predicting human drug toxicity and safety via animal tests: Can any one species predict drug toxicity in any other, and do monkeys help?ATLA, 43, 393–403.
36.
HuangR., XiaM., SakamuruS., ZhaoJ., ShahaneS.A., Attene-RamosM., ZhaoT., AustinC.P., & SimeonovA. (2016). Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization. Nature Communications7, 10425.
37.
EC (2013). Report from the Commission to the Council and the European Parliament. Seventh Report on the Statistics on the Number of Animals Used for Experimental and Other Scientific Purposes in the Member States of the European Union, COM(2013) 859 final, 14 pp. Brussels, Belgium: European Commission. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52013DC0859&from=EN (Accessed 08.03.16).
EC (undated).Horizon 2020. The EU Framework Programme for Research and Innovation.Brussels, Belgium: European Commission. Available at: https://ec.europa.eu/programmes/horizon2020/ (Accessed 08.03.16).
40.
Contopoulos-IoannidisD.G., NtzaniE., & IoannidisJ.P. (2003). Translation of highly promising basic science research into clinical applications. American Journal of Medicine114, 477–484.
41.
CrowleyW.F.Jr. (2003). Translation of basic research into useful treatments: How often does it occur?American Journal of Medicine, 114, 503–505.
42.
IoannidisJ.P. (2006). Evolution and translation of research findings: From bench to where?PLoS Clinical Trials, 1, e36.
43.
SeokJ., WarrenH.S., CuencaA.G., MindrinosM.N., BakerH.V., XuW., RichardsD.R., McDonald-SmithG.P., GaoH., HennessyL., FinnertyC.C., LopezC.M., HonariS., MooreE.E., MineiJ.P., CuschieriJ., BankeyP.E., JohnsonJ.L., SperryJ., NathensA.B., BilliarT.R., WestM.A., JeschkeM.G., KleinM.B., GamelliR.L., GibranN.S., BrownsteinB.H., Miller-GrazianoC., CalvanoS.E., MasonP.H., CobbJ.P., RahmeL.G., LowryS.F., MaierR.V., MoldawerL.L., HerndonD.N., DavisR.W., XiaoW., & TompkinsR.G. (2014). Genomic responses in mouse models poorly mimic human inflammatory diseases. Proceedings of the National Academy of Sciences of the USA110, 3507–3512.
44.
MestasJ., & HughesC.C. (2004). Of mice and not men: Differences between mouse and human immunology. Journal of Immunology172, 2731–2738.
45.
YueF., ChengY., BreschiA., VierstraJ., WuW., RybaT., SandstromR., MaZ., DavisC., PopeB.D., ShenY., PervouchineD.D., DjebaliS., ThurmanR.E., KaulR., RynesE., KirilushaA., MarinovG.K., WilliamsB.A., TroutD., AmrheinH., Fisher-AylorK., AntoshechkinI., DeSalvoG., SeeL.H., FastucaM., DrenkowJ., ZaleskiC., DobinA., PrietoP., LagardeJ., BussottiG., TanzerA., DenasO., LiK., BenderM.A., ZhangM., ByronR., GroudineM.T., McClearyD. (2014). A comparative encyclopedia of DNA elements in the mouse genome. Nature, London515, 355–364.
46.
ChibaM., NishimeJ.A., NewayW., LinY., & LinJ.H. (2000). Comparative in vitro metabolism of indinavir in primates — a unique stereoselective hydroxylation in monkey. Xenobiotica30, 117–129.
47.
DuboisV.F., de WitteW.E., VisserS.A., DanhofM., & Della PasquaO.; Cardiovascular Safety Project Team; TI Pharma PKPD Platform (2006). Assessment of interspecies differences in drug-induced QTc interval prolongation in cynomolgus monkeys, dogs and humans. Pharmaceutical Research33, 40–51.
48.
TristH.M., TanP.S., WinesB.D., RamslandP.A., OrlowskiE., StubbsJ., GardinerE.E., PieterszG.A., KentS.J., StratovI., BurtonD.R., & HogarthP.M. (2014). Polymorphisms and inter-species differences of the activating and inhibitory FcyRII of Macaca nemestrina influence the binding of human IgG subclasses. Journal of Immunology192, 792–803.
49.
YanG., ZhangG., FangX., ZhangY., LiC., LingF., CooperD.N., LiQ., LiY., van GoolA.J., DuH., ChenJ., ChenR., ZhangP., HuangZ., ThompsonJ.R., MengY., BaiY., WangJ., ZhuoM., WangT., HuangY., WeiL., LiJ., WangZ., HuH., YangP., LeL., StensonP.D., LiB., LiuX., BallE.V., AnN., HuangQ., ZhangY., FanW., ZhangX., LiY., WangW., KatzeM.G. (2011). Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques. Nature Biotechnology29, 1019–1023.
50.
GreekR., & RiceM.J. (2012). Animal models and conserved processes. Theoretical Biology & Medical Modelling9, 40.
51.
van RegenmortelM.H.V. (2004). Reductionism and complexity in molecular biology. EMBO Reports5, 1016–1020.
52.
KochC. (2012). Systems biology. Modular biological complexity. Science, New York337, 531–532.
AltevogtB.M., PankevichD.E., Shelton-DavenportM.K., & KahnJ.P. (eds) (2011). Chimpanzees in Biomedical and Behavioral Research. Assessing the Necessity, 200 pp. Washington, DC, USA: The National Academies Press.
KnightA. (2007). Systematic reviews of animal experiments demonstrate poor human clinical and toxicological utility. ATLA35, 641–659.
68.
BallsM., & CombesR. (2005). The need for a formal invalidation process for animal and non-animal tests. ATLA33, 299–308.
69.
GodleeF. (2014). How predictive and productive is animal research?British Medical Journal, 348, g3719.
70.
PoundP., BrackenM.B., & BlissS.D. (2014). Is animal research sufficiently evidence based to be a cornerstone of biomedical research?British Medical Journal, 348, g3387.
